Clinical Trials Directory

Trials / Completed

CompletedNCT04710459

Endobronchial Cryotherapy in Management of MEBO in Patients With Inoperable NSCLC

The Value of Endobronchial Cryotherapy in the Management of Malignant Endobronchial Obstruction in Patients With Inoperable NSCLC: A Prospective Analysis of Clinical and Survival Outcomes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Mohamed Abdel Bary Ahmed Ibrahim · Academic / Other
Sex
All
Age
47 Years – 71 Years
Healthy volunteers

Summary

Background: In end-stage patients when all management options have been used, will often develop compromise of their airways as the cancer continues to progress. Endobronchial therapy options may help to relieve some of their symptoms, allowing improvement in their shortness of breath as they go home in combination with other palliative therapies. Objective: to compare the safety ; efficacy; and clinical outcome of endobronchial cryotherapy combined with chemotherapy and/ or radiotherapy versus chemo-radiotherapy alone on patients with Non small cell lung cancer. Patients and method(s): A prospective randomized clinical trial was carried out on 60 patients with different ages of both sexes, diagnosed as bronchogenic carcinoma non-small cell lung cancer type (NSCLC) . The patients attended the hospital in the chest department, Qena Faculty of Medicine, South Valley University. Assessment of the patients was done and randomly assigned into two groups. Group1 ,Include 30 patients subjected to chemotherapy , radiotherapy and endobronchial cryotherapy.Group 2 , Include include 30 patients subjected to chemotherapy and radiotherapy alone.

Conditions

Interventions

TypeNameDescription
PROCEDUREcryotherapyGroup 1 included 30 patients, they were subjected to chemoradiotherapy plus endobronchial cryotherapy. Group 2 included include 30 patients, they were subjected to chemoradiotherapy.

Timeline

Start date
2016-12-01
Primary completion
2019-04-01
Completion
2019-05-01
First posted
2021-01-14
Last updated
2021-03-08

Source: ClinicalTrials.gov record NCT04710459. Inclusion in this directory is not an endorsement.